Ovarian Germ Cell Tumours: A 17-year Study in a Single Unit

Abstract

Background/Purpose: The aim of this study was to evaluate the clinical presentation, management and outcome in girls treated for ovarian germ cell tumours at a single unit.

Methods: The records of 40 girls (median age 10.5 years) with histologically proven ovarian germ cell tumours operated upon between 1990 and 2007 were reviewed.

Results: Twenty-nine patients had mature teratomas (MT), 5 patients had immature teratomas (IT) and 6 had malignant tumours: 4 malignant mixed germ cell tumours (MMGCT) and 2 germinomas (G). The median age at presentation was 11 years for the MT and IT groups and 8.5 years for the malignant group. The commonest symptoms and signs at presentation were pain (n=28), a palpable mass (n=15) and abdominal distension (n=9). Precocious puberty was noted at presentation in three patients with malignant tumours. Tumour markers were elevated at presentation in all patients with MMGCT. At operation, 14 patients with MT had ovarian torsion. Open unilateral oophorectomy was the procedure most frequently performed (n=30). Surgery alone was the treatment for all patients with MT and IT. Of the patients with malignant tumours, 1 had stage I, 2 had stage II, 1 had stage III and 1 had stage IV disease. All 40 patients are now between 8 months and 17 years post treatment with no contralateral tumours identified. There was one recurrence in a patient with IT, with raised tumour markers.

Conclusions: Ovarian germ cell tumours are uncommon in childhood. Tumour markers are valuable both pre and post-operatively. Malignancy is a risk regardless of age. Surgery is curative in the majority of cases. The overall outlook is very good. However, a close collaboration between surgeons, histologists, radiologists and oncologists is essential to achieve good outcomes.

Key words

ovarian tumours - germ cell tumours - teratomas - malignant germ - cell tumours

References

• 1 Billmire D, Vinocur C, Rescorla F. et al . Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.  J Pediatr Surg. 2004;  39 424-429 , discussion 424–429
• 2 von Allmen D. Malignant lesions of the ovary in childhood.  Semin Pediatr Surg. 2005;  14 100-105
• 3 Gribbon M, Ein SH, Mancer K. Pediatric malignant ovarian tumors: a 43-year review.  J Pediatr Surg. 1992;  27 480-484
• 4 Skinner MA, Schlatter MG, Heifetz SA, Grosfeld JL. Ovarian neoplasms in children.  Arch Surg. 1993;  128 849-853 , discussion 853–844
• 5 Brown MF, Hebra A, MacGeehin K, Ross  3rd  AJ. Ovarian masses in children: a review of 91 cases of malignant and benign masses.  J Pediatr Surg. 1993;  28 930-933
• 6 Schultz KA, Sencer SF, Messinger Y, Neglia JP, Steiner ME. Pediatric ovarian tumors: a review of 67 cases.  Pediatr Blood Cancer. 2005;  44 167-173
• 7 De Backer A, Madern GC, Oosterhuis JW, Hakvoort-Cammel FG, Hazebroek FW. Ovarian germ cell tumors in children: a clinical study of 66 patients.  Pediatr Blood Cancer. 2006;  46 459-464
• 8 van Winter JT, Simmons PS, Podratz KC. Surgically treated adnexal masses in infancy, childhood, and adolescence.  Am J Obstet Gynecol. 1994;  170 1780-1786 , discussion 1786–1789
• 9 Cass D, Hawkins E, Brandt ML. Surgery for ovarian masses in infants, children and adolescents: 102 consecutive patients treated in a 15-year period.  J Pediatr Surg. 2001;  36 693-699
• 10 Sandoval C, Strom K, Stringel G. Laparoscopy in the management of pediatric intraabdominal tumors.  JSLS. 2004;  8 115-118
• 11 Templeman CL, Fallat ME, Lam AM. et al . Managing mature cystic teratomas of the ovary.  Obstet Gynecol Surv. 2000;  55 738-745
• 12 Akyuz C, Varan A, Buyukpamukcu N, Kutluk T, Buyukpamukcu M. Malignant ovarian tumors in children: 22 years of experience at a single institution.  J Pediatr Hematol Oncol. 2000;  22 422-427
• 13 Terenziani M, Massimino M, Casanova M. et al . Childhood malignant ovarian germ cell tumors: a monoinstitutional experience.  Gynecol Oncol. 2001;  81 436-440
• 14 De Backer A, Madern GC, Pieters R. et al . Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.  Eur J Pediatr Surg. 2008;  18 1-6
• 15 Baranzelli MC, Bouffet E, Quintana E. et al . Non-seminomatous ovarian germ cell tumours in children.  Eur J Cancer. 2000;  36 376-383
• 16 Cushing B, Giller R, Ablin AR. et al . Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children’s cancer group.  Am J Obstet Gynecol. 1999;  181 353-358
• 17 Marina N, Cushing B, Giller R. et al . Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children’s Cancer Group Intergroup study.  J Clin Oncol. 1999;  17 2137-2143
• 18 Mann JR, Raafat F, Robinson K. et al . The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.  J Clin Oncol. 2000;  18 3809-3818
• 19 Brewer M, Gershenson DM, Herzog CE. et al . Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.  J Clin Oncol. 1999;  17 2670-2675
• 20 Zanetta G, Bonazzi C, Cantu M. et al . Survival and reproductive function after treatment of malignant germ cell ovarian tumors.  J Clin Oncol. 2001;  19 1015-1020
• 21 Sagae S, Sasaki H, Nishioka Y, Terasawa K, Kudo R. Reproductive function after treatment of malignant germ cell ovarian tumors.  Mol Cell Endocrinol. 2003;  202 117-121

Correspondence